Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
BMJ Open|December 25, 2015
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activityThierry Poynard, Olivier Deckmyn, Mona Munteanu, et al.
The American Journal of Gastroenterology|June 15, 2006
Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?Dominique Thabut, Sophie Le Calvez, Vincent Thibault, et al.
Antiviral Therapy|July 1, 2010
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studiesThierry Poynard, Yen Ngo, Mona Munteanu, et al.
European Journal of Gastroenterology & Hepatology|December 28, 2017
Impact of steatosis and inflammation definitions on the performance of NASH testsThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.
Gastroenterology & Hepatology|February 3, 2012
Prognostic value of liver fibrosis biomarkers: a meta-analysisThierry Poynard, Yen Ngo, Hugo Perazzo, et al.
Rheumatology (Oxford, England)|August 22, 2012
Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infectionBenjamin Terrier, Frédéric Jehan, Mona Munteanu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 29, 2021
Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosisNicolas Asesio, Priscila Pollo-Flores, Olivier Caliez, et al.
Journal of Hepatology|May 23, 2012
Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large populationThierry Poynard, Mona Munteanu, Olivier Deckmyn, et al.
Clinical Chemistry|July 20, 2007
Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stagesThierry Poynard, Philippe Halfon, Laurent Castera, et al.
Plos One|August 8, 2015
Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic HepatitisMarika Rudler, Sarah Mouri, Frederic Charlotte, et al.
Pageof 8